Sex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cells

Lung Cancer

Volumn 71, Issue 3, 2011, Pages 264-270

  Uppstad, Heidi ^a   Osnes, Gro Helene ^a   Cole, Kathleen J ^b   Phillips, David H ^b   Haugen, Aage ^a   Mollerup, Steen ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Benzo a pyrene; Cigarette smoke condensate; CYP1A1; CYP1B1; DNA adducts; EROD assay; Gene expression; Sex differences

Indexed keywords

BENZO[A]PYRENE; CARBON; CIGARETTE SMOKE CONDENSATE; CYTOCHROME P450; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA ADDUCT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE;

ADENOCARCINOMA; ARYL HYDROCARBON HYDROXYLASES; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BENZO(A)PYRENE; CARCINOGENS; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DISEASE SUSCEPTIBILITY; DNA ADDUCTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; POLYCYCLIC HYDROCARBONS, AROMATIC; RECEPTORS, ARYL HYDROCARBON; REPRESSOR PROTEINS; SEX FACTORS; TARS;

EID: 79851507943     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.09.006     Document Type: Article

References (47)

1. Bray F., Sankila R., Ferlay J., Parkin D.M. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002, 1:99-166.
2. Centers for Disease Control and Prevention (CDC) Recent trends in mortality rates for four major cancers, by sex and race/ethnicity United States, 1990-1998 2002, 3. MMWR Morb Mortal Wkly Rep, p. 49-53.
3. Jemal A., Travis W.D., Tarone R.E., Travis L., Devesa S.S. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer 2003, 1:101-107.
4. Zang E.A., Wynder E.L. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996, 3-4:183-192.
5. Ramchandran K., Patel J.D. Sex differences in susceptibility to carcinogens. Semin Oncol 2009, 6:516-523.
6. Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 2004, 38:6392-6403.
7. Amr S., Wolpert B., Loffredo C.A., Zheng Y.L., Shields P.G., Jones R., et al. Occupation, gender, race, and lung cancer. J Occup Environ Med 2008, 50:1167-1175.
8. Risch H.A., Howe G.R., Jain M., Burch J.D., Holowaty E.J., Miller A.B. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993, 5:281-293.
9. Osann K.E., Anton-Culver H., Kurosaki T., Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993, 1:44-48.
10. Bain C., Feskanich D., Speizer F.E., Thun M., Hertzmark E., Rosner B.A., et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 2004, 11:826-834.
11. Henschke C.I., Yip R., Miettinen O.S. International early lung cancer action program investigators: women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006, 2:180-184.
12. Metayer C., Wang Z., Kleinerman R.A., Wang L., Brenner A.V., Cui H., et al. Cooking oil fumes and risk of lung cancer in women in rural Gansu, China. Lung Cancer 2002, 2:111-117.
13. Keohavong P., Lan Q., Gao W.M., DeMarini D.M., Mass M.J., Li X.M., et al. K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China. Lung Cancer 2003, 1:21-27.
14. Mollerup S., Berge G., Bæra R., Skaug V., Hewer A., Phillips D.H., et al. Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts. Int J Cancer 2006, 4:741-744.
15. Ryberg D., Hewer A., Phillips D.H., Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994, 22:5801-5803.
16. Mollerup S., Ryberg D., Hewer A., Phillips D.H., Haugen A. Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res 1999, 14:3317-3320.
17. Ben-Zaken Cohen S., Paré P.D., Man S.F., Sin D.D. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med 2007, 2:113-120.
18. Shimada T., Guengerich F.P. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Chem Res Toxicol 2006, 2:288-294.
19. Uppstad H., Øvrebø S., Haugen A., Mollerup S. Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines. Toxicol Lett 2010, 1:221-228.
20. Veglia F., Loft S., Matullo G., Peluso M., Munnia A., Perera F., et al. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis. Carcinogenesis 2008, 5:932-936.
21. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., et al. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res 1992, 22:6248-6253.
22. McLemore T.L., Adelberg S., Liu M.C., McMahon N.A., Yu S.J., Hubbard W.C., et al. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst 1990, 16:1333-1339.
23. Haugen A. Women who smoke: are women more susceptible to tobacco-induced lung cancer?. Carcinogenesis 2002, 2:227-229.
24. Mollerup S., Jørgensen K., Berge G., Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002, 2:153-159.
25. Phillips D.H., Arlt V.M. The 32P-postlabelling assay for DNA adducts. Nature Protocols 2007, 2:2772-2781.
26. Sapan C.V., Lundblad R.L., Price N.C. Colorimetric protein assay techniques. Biotechnol Appl Biochem 1999, 2:99-108.
27. Bartsch H., Castegnaro M., Rojas M., Camus A.M., Alexandrov K., Lang M. Expression of pulmonary cytochrome P4501A1 and carcinogen-DNA adduct formation in high risk subjects for tobacco-related lung cancer. Toxicol Lett 1992, 64:477-483.
28. Bartsch H., Petruzzelli S., De Flora S Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case-control multicenter study on lung cancer patients. Environ Health Perspect 1992, 98:119-124.
29. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking summary of data reported and evaluation; 2004, vol. 83.
30. Iba M.M., Scholl H., Fung J., Thomas P.E., Alam J. Induction of pulmonary CYP1A1 by nicotine. Xenobiotica 1998, 28:827-843.
31. Wilson C.L., Bodnar J.A., Brown B.G., Morgan W.T., Potts R.J., Borgerding M.F. Assessment of dioxin and dioxin-like compounds in mainstream smoke from selected US cigarette brands and reference cigarettes. Food Chem Toxicol 2008, 46:1721-1733.
32. Sagredo C., Øvrebø S., Haugen A., Fujii-Kuriyama Y., Bæra R., Botnen I.V., et al. Quantitative analysis of benzo[a]pyrene biotransformation and adduct formation in Ahr knockout mice. Toxicol Lett 2006, 3:173-182.
33. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2000, 97:779-782.
34. Abdelrahim M., Smith R 3rd, Safe S Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. Mol Pharmacol 2003, 6:1373-1381.
35. Sissung T.M., Price D.K., Sparreboom A., Figg W.D. Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol Cancer Res 2006, 3:135-150.
36. Chang J.T., Chang H., Chen P.H., Lin S.L., Lin P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res 2007, 1:38-45.
37. Mimura J., Ema M., Sogawa K., Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 1999, 1:20-25.
38. Kreuzer M., Gerken M., Heinrich J., Kreienbrock L., Wichmann H.E. Hormonal factors and risk of lung cancer among women. Int J Epidemiol 2003, 2:263-271.
39. Thomsen J.S., Wang X., Hines R.N., Safe S. Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 1994, 15:933-937.
40. Ricci M.S., Toscano D.G., Mattingly C.J., Toscano W.A. Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J Biol Chem 1999, 6:3430-3438.
41. Wu C.T., Chang Y.L., Shih J.Y., Lee Y.C. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005, 4:979-986.
42. Omoto Y., Kobayashi Y., Nishida K., Tsuchiya E., Eguchi H., Nakagawa K., et al. Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun 2001, 2:340-347.
43. Patrone C., Cassel T.N., Pettersson K., Piao Y.S., Cheng G., Ciana P., et al. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol 2003, 23:8542-8552.
44. Dougherty S.M., Mazhawidza W., Bohn A.R., Robinson K.A., Mattingly K.A., Blankenship K.A., et al. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer 2006, 1:113-134.
45. Ivanova M.M., Mazhawidza W., Dougherty S.M., Minna J.D., Klinge C.M. Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells. Mol Cell Endocrinol 2009, 1-2:12-21.
46. Penaloza C., Estevez B., Orlanski S., Sikorska M., Walker R., Smith C., et al. Sex of the cell dictates its response: differential gene expression and sensitivity to cell death inducing stress in male and female cells. FASEB J 2009, 6:1869-1879.
47. Kojima M., Sekimoto M., Degawa M. A novel gender-related difference in the constitutive expression of hepatic cytochrome P4501A subfamily enzymes in Meishan pigs. Biochem Pharmacol 2008, 5:1076-1082.